Loading...

Georgia Healthcare Group

BST:1EB
Snowflake Description

Proven track record with reasonable growth potential.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
1EB
BST
£265M
Market Cap
  1. Home
  2. DE
  3. Consumer Retailing
Company description

Georgia Healthcare Group PLC, together with its subsidiaries, provides healthcare services in Georgia. The last earnings update was 15 days ago. More info.


Add to Portfolio Compare Print
1EB Share Price and Events
7 Day Returns
0.9%
BST:1EB
0.8%
Europe Consumer Retailing
2.3%
DE Market
1 Year Returns
-
BST:1EB
2.5%
Europe Consumer Retailing
-7.2%
DE Market
1EB Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Georgia Healthcare Group (1EB) 0.9% 4.6% 4.6% - - -
Europe Consumer Retailing 0.8% 1.7% 4.6% 2.5% -5.4% -9.2%
DE Market 2.3% 3.1% 8.8% -7.2% 9.3% 12.3%
1 Year Return vs Industry and Market
  • No trading data on 1EB.
  • No trading data on 1EB.
Price Volatility
1EB
Industry
5yr Volatility vs Market

1EB Value

 Is Georgia Healthcare Group undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Georgia Healthcare Group to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Georgia Healthcare Group.

BST:1EB Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 4 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 5.5%
Perpetual Growth Rate 10-Year DE Government Bond Rate 0.2%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for BST:1EB
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate 0.2%
Equity Risk Premium S&P Global 6.7%
Consumer Retailing Unlevered Beta Simply Wall St/ S&P Global 0.47
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.465 (1 + (1- 19%) (42.88%))
0.75
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.8
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.23% + (0.8 * 6.65%)
5.55%

Discounted Cash Flow Calculation for BST:1EB using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Georgia Healthcare Group is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

BST:1EB DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (GEL, Millions) Source Present Value
Discounted (@ 5.55%)
2019 63.00 Analyst x1 59.69
2020 114.10 Analyst x2 102.42
2021 137.90 Analyst x2 117.28
2022 163.00 Analyst x1 131.34
2023 182.16 Est @ 11.75% 139.06
2024 197.27 Est @ 8.3% 142.68
2025 208.86 Est @ 5.88% 143.12
2026 217.60 Est @ 4.18% 141.27
2027 224.12 Est @ 3% 137.86
2028 228.97 Est @ 2.17% 133.44
Present value of next 10 years cash flows GEL1,248.15
BST:1EB DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= GEL228.97 × (1 + 0.23%) ÷ (5.55% – 0.23%)
GEL4,313.74
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= GEL4,313.74 ÷ (1 + 5.55%)10
GEL2,513.93
BST:1EB Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= GEL1,248.15 + GEL2,513.93
GEL3,762.09
Equity Value per Share
(GEL)
= Total value / Shares Outstanding
= GEL3,762.09 / 128.74
GEL26.4
BST:1EB Discount to Share Price
Calculation Result
Exchange Rate GEL/GBP
(Reporting currency to currency of LSE:GHG)
0.285
Value per Share
(GBP)
= Value per Share in GEL x Exchange Rate (GEL/GBP)
= GEL29.22 x 0.285
£8.33
Non-primary Listing Adjustment Factor 1 share in BST:1EB represents 1.10679x of LSE:GHG
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
1.10679x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (GBP) x Listing Adjustment Factor
= £ 8.33 x 1.10679
€9.22
Value per share (EUR) From above. €9.22
Current discount Discount to share price of €2.28
= -1 x (€2.28 - €9.22) / €9.22
75.3%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Georgia Healthcare Group is available for.
Intrinsic value
>50%
Share price is €2.28 vs Future cash flow value of €9.22
Current Discount Checks
For Georgia Healthcare Group to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Georgia Healthcare Group's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Georgia Healthcare Group's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Georgia Healthcare Group's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Georgia Healthcare Group's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
BST:1EB PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in GEL GEL0.27
LSE:GHG Share Price ** LSE (2019-04-17) in GBP £2.06
LSE:GHG Share Price converted to GEL reporting currency Exchange rate (GBP/ GEL) 3.509 GEL7.23
Europe Consumer Retailing Industry PE Ratio Median Figure of 32 Publicly-Listed Consumer Retailing Companies 19.4x
Germany Market PE Ratio Median Figure of 422 Publicly-Listed Companies 19.43x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Georgia Healthcare Group.

BST:1EB PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= LSE:GHG Share Price ÷ EPS (both in GEL)

= 7.23 ÷ 0.27

27.03x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Georgia Healthcare Group is overvalued based on earnings compared to the Europe Consumer Retailing industry average.
  • Georgia Healthcare Group is overvalued based on earnings compared to the Germany market.
Price based on expected Growth
Does Georgia Healthcare Group's expected growth come at a high price?
Raw Data
BST:1EB PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 27.03x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 4 Analysts
27.7%per year
Europe Consumer Retailing Industry PEG Ratio Median Figure of 24 Publicly-Listed Consumer Retailing Companies 1.69x
Germany Market PEG Ratio Median Figure of 272 Publicly-Listed Companies 1.56x

*Line of best fit is calculated by linear regression .

BST:1EB PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 27.03x ÷ 27.7%

0.98x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Georgia Healthcare Group is good value based on expected growth next year.
Price based on value of assets
What value do investors place on Georgia Healthcare Group's assets?
Raw Data
BST:1EB PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in GEL GEL3.95
LSE:GHG Share Price * LSE (2019-04-17) in GBP £2.06
LSE:GHG Share Price converted to GEL reporting currency Exchange rate (GBP/ GEL) 3.509 GEL7.23
Europe Consumer Retailing Industry PB Ratio Median Figure of 41 Publicly-Listed Consumer Retailing Companies 1.55x
Germany Market PB Ratio Median Figure of 570 Publicly-Listed Companies 1.87x
BST:1EB PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= LSE:GHG Share Price ÷ Book Value per Share (both in GEL)

= 7.23 ÷ 3.95

1.83x

* Primary Listing of Georgia Healthcare Group.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Georgia Healthcare Group is overvalued based on assets compared to the Europe Consumer Retailing industry average.
X
Value checks
We assess Georgia Healthcare Group's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Consumer Retailing industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Consumer Retailing industry average (and greater than 0)? (1 check)
  5. Georgia Healthcare Group has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

1EB Future Performance

 How is Georgia Healthcare Group expected to perform in the next 1 to 3 years based on estimates from 4 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
27.7%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Georgia Healthcare Group expected to grow at an attractive rate?
  • Georgia Healthcare Group's earnings growth is expected to exceed the low risk savings rate of 0.2%.
Growth vs Market Checks
  • Georgia Healthcare Group's earnings growth is expected to exceed the Germany market average.
  • Georgia Healthcare Group's revenue growth is expected to exceed the Germany market average.
Annual Growth Rates Comparison
Raw Data
BST:1EB Future Growth Rates Data Sources
Data Point Source Value (per year)
BST:1EB Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 4 Analysts 27.7%
BST:1EB Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 4 Analysts 8.6%
Europe Consumer Retailing Industry Earnings Growth Rate Market Cap Weighted Average 12.2%
Europe Consumer Retailing Industry Revenue Growth Rate Market Cap Weighted Average 3.8%
Germany Market Earnings Growth Rate Market Cap Weighted Average 11.7%
Germany Market Revenue Growth Rate Market Cap Weighted Average 4.8%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
BST:1EB Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 4 Analyst Estimates (S&P Global) See Below
All numbers in GEL Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
BST:1EB Future Estimates Data
Date (Data in GEL Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2022-12-31 1,201 188 117 2
2021-12-31 1,117 169 96 4
2020-12-31 1,033 147 74 4
2019-12-31 949 116 52 4
BST:1EB Past Financials Data
Date (Data in GEL Millions) Revenue Cash Flow Net Income *
2018-12-31 846 100 34
2018-09-30 817 32
2018-06-30 794 78 32
2018-03-31 767 31
2017-12-31 746 58 29
2017-09-30 684 27
2017-06-30 620 50 28
2017-03-31 537 49
2016-12-31 424 42 50
2016-09-30 357 51 49
2016-06-30 305 43 45
2016-03-31 262 24

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Georgia Healthcare Group's earnings are expected to grow significantly at over 20% yearly.
  • Georgia Healthcare Group's revenue is expected to grow by 8.6% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
BST:1EB Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 4 Analyst Estimates (S&P Global) See Below

All data from Georgia Healthcare Group Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BST:1EB Future Estimates Data
Date (Data in GEL Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2022-12-31 0.89 0.89 0.89 1.00
2021-12-31 0.73 0.76 0.70 2.00
2020-12-31 0.56 0.59 0.54 2.00
2019-12-31 0.39 0.41 0.38 2.00
BST:1EB Past Financials Data
Date (Data in GEL Millions) EPS *
2018-12-31 0.27
2018-09-30 0.25
2018-06-30 0.25
2018-03-31 0.24
2017-12-31 0.23
2017-09-30 0.20
2017-06-30 0.22
2017-03-31 0.38
2016-12-31 0.39
2016-09-30 0.38
2016-06-30 0.27
2016-03-31 0.19

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Georgia Healthcare Group is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Georgia Healthcare Group's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Europe market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Georgia Healthcare Group has a total score of 4/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

1EB Past Performance

  How has Georgia Healthcare Group performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Georgia Healthcare Group's growth in the last year to its industry (Consumer Retailing).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Georgia Healthcare Group has delivered over 20% year on year earnings growth in the past 5 years.
  • Georgia Healthcare Group's 1-year earnings growth is less than its 5-year average (18.3% vs 20.3%)
  • Georgia Healthcare Group's earnings growth has exceeded the Europe Consumer Retailing industry average in the past year (18.3% vs -4.5%).
Earnings and Revenue History
Georgia Healthcare Group's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Georgia Healthcare Group Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BST:1EB Past Revenue, Cash Flow and Net Income Data
Date (Data in GEL Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 846.31 34.43 139.58
2018-09-30 817.24 32.35 139.22
2018-06-30 793.65 32.30 135.17
2018-03-31 766.88 30.82 130.43
2017-12-31 745.71 29.11 126.15
2017-09-30 683.67 26.67 115.46
2017-06-30 620.40 27.53 103.62
2017-03-31 537.41 49.11 89.33
2016-12-31 423.75 50.20 68.23
2016-09-30 357.16 48.63 57.55
2016-06-30 305.27 45.47 48.72
2016-03-31 261.61 23.84 42.93
2015-12-31 242.36 19.65 40.48
2015-09-30 230.14 15.93 43.27
2015-06-30 211.67 17.58 39.67
2015-03-31 195.94 13.86 30.08
2014-12-31 196.33 10.21 34.39
2014-09-30 182.94 11.69 26.11
2013-12-31 157.47 9.63 19.38

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Georgia Healthcare Group has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Georgia Healthcare Group used its assets more efficiently than the Europe Consumer Retailing industry average last year based on Return on Assets.
  • Georgia Healthcare Group has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Georgia Healthcare Group's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Consumer Retailing industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Georgia Healthcare Group has a total score of 4/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

1EB Health

 How is Georgia Healthcare Group's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Georgia Healthcare Group's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Georgia Healthcare Group is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Georgia Healthcare Group's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Georgia Healthcare Group's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Georgia Healthcare Group Company Filings, last reported 3 months ago.

BST:1EB Past Debt and Equity Data
Date (Data in GEL Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 575.03 399.07 46.89
2018-09-30 563.96 384.68 31.90
2018-06-30 558.11 371.41 25.31
2018-03-31 552.81 367.92 45.67
2017-12-31 548.40 369.34 56.42
2017-09-30 543.91 329.20 42.79
2017-06-30 534.65 283.42 23.91
2017-03-31 520.92 321.09 100.23
2016-12-31 542.03 238.46 44.76
2016-09-30 514.96 195.19 48.07
2016-06-30 507.23 150.14 24.30
2016-03-31 476.00 99.86 65.40
2015-12-31 474.98 152.76 155.26
2015-09-30
2015-06-30
2015-03-31
2014-12-31 172.31 162.86 38.31
2014-09-30
2013-12-31
  • Georgia Healthcare Group's level of debt (69.4%) compared to net worth is high (greater than 40%).
  • Unable to establish if Georgia Healthcare Group's debt level has increased without past 5-year debt data.
  • Debt is well covered by operating cash flow (25%, greater than 20% of total debt).
  • Interest payments on debt are not well covered by earnings (EBIT is 2.6x annual interest expense, ideally 3x coverage).
X
Financial health checks
We assess Georgia Healthcare Group's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Georgia Healthcare Group has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

1EB Dividends

 What is Georgia Healthcare Group's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0.73%
Current annual income from Georgia Healthcare Group dividends. Estimated to be 2.14% next year.
If you bought €2,000 of Georgia Healthcare Group shares you are expected to receive €15 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Georgia Healthcare Group's pays a lower dividend yield than the bottom 25% of dividend payers in Germany (1.43%).
  • Georgia Healthcare Group's dividend is below the markets top 25% of dividend payers in Germany (3.71%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
BST:1EB Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 4 Analyst Estimates (S&P Global) See Below
Europe Consumer Retailing Industry Average Dividend Yield Market Cap Weighted Average of 34 Stocks 3.7%
Germany Market Average Dividend Yield Market Cap Weighted Average of 325 Stocks 3.1%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.4%
Germany Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

BST:1EB Future Dividends Estimate Data
Date (Data in GEL) Dividend per Share (annual) Avg. No. Analysts
2022-12-31 0.23 1.00
2021-12-31 0.23 2.00
2020-12-31 0.13 2.00
2019-12-31 0.07 2.00
BST:1EB Past Annualized Dividends Data
Date (Data in GEL) Dividend per share (annual) Avg. Yield (%)
2019-04-10 0.053 0.718

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Georgia Healthcare Group is not paying a notable dividend for Germany, therefore no need to check if the payments are stable.
  • Georgia Healthcare Group is not paying a notable dividend for Germany, therefore no need to check if the payments are increasing.
Current Payout to shareholders
What portion of Georgia Healthcare Group's earnings are paid to the shareholders as a dividend.
  • No need to calculate the sustainability of Georgia Healthcare Group's dividends as it is not paying a notable one for Germany.
Future Payout to shareholders
  • Dividends after 3 years are expected to be well covered by earnings (3.2x coverage).
X
Income/ dividend checks
We assess Georgia Healthcare Group's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Georgia Healthcare Group afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Georgia Healthcare Group has a total score of 1/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

1EB Management

 What is the CEO of Georgia Healthcare Group's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Nick Gamkrelidze
COMPENSATION GEL1,297,055
AGE 38
TENURE AS CEO 3.7 years
CEO Bio

Mr. Nikoloz Gamkrelidze, also known as Nick, has been the Chief Executive Officer of Georgia Healthcare Group PLC since august 8, 2015. Mr. Gamkrelidze served as Group Chief Financial Officer and Deputy Chief Executive Officer of Finance at Bank of Georgia Holdings plc since October 2012. He served as Chief Executive Officer of Georgia Healthcare Group and Member of Management Board at Bank of Georgia Holdings plc. He served as Chief Executive Officer at JSC Insurance Company Aldagi BCI. He served as the Chief Executive Officer of Aldagi BCI at JSC Bank of Georgia since November 2007. He served as Deputy Chief Executive Officer of Finance at JSC Bank of Georgia since October 2012. From 2005 to 2007, he served as Chief Executive Officer of “My Family Clinic” and from 2007 to 2012 served as Chief Executive Officer of largest insurance company in Georgia – Aldagi BCI. Mr. Gamkrelidze has been Executive Director of Georgia Healthcare Group PLC since May 26, 2016. He served as Member of Supervisory Board of Joint Stock Company Belarusky Narodny Bank. Mr. Gamkrelidze managed several World Bank projects. He graduated from Tbilisi State Medical University and received his master’s degree in public health from London College and holds an MA in International Healthcare Management from the Tanaka Business School of Imperial College London.

CEO Compensation
  • Nick's compensation has been consistent with company performance over the past year.
  • Nick's remuneration is higher than average for companies of similar size in Germany.
Management Team Tenure

Average tenure of the Georgia Healthcare Group management team in years:

3.8
Average Tenure
  • The tenure for the Georgia Healthcare Group management team is about average.
Management Team

Nick Gamkrelidze

TITLE
CEO & Executive Director
COMPENSATION
GEL1M
AGE
38
TENURE
3.7 yrs

Irakli Gogia

TITLE
Chief Financial Officer
COMPENSATION
GEL371K
TENURE
2.1 yrs

Ketevan Kalandarishvili

TITLE
Head of Investor Relations

Nino Kortua

TITLE
Chief Legal Officer
TENURE
4 yrs

Nino Chichua

TITLE
Chief Marketing and Communications Officer
TENURE
4 yrs

Enrico Beridze

TITLE
Head of Business Development & Strategic Marketing

Medea Chkhaidze

TITLE
Chief Human Resource Officer
TENURE
4 yrs

David Vakhtangishvili

TITLE
Deputy CEO of Risks & IT
COMPENSATION
GEL371K
AGE
40
TENURE
2.1 yrs

Gia Khurtsidze

TITLE
Deputy Chief Executive Officer of Clinical
TENURE
3.2 yrs

Giorgi Mindiashvili

TITLE
Chief Operating Officer of Hospitals
COMPENSATION
GEL376K
TENURE
4.1 yrs
Board of Directors Tenure

Average tenure and age of the Georgia Healthcare Group board of directors in years:

3.6
Average Tenure
62.5
Average Age
  • The tenure for the Georgia Healthcare Group board of directors is about average.
Board of Directors

Bill Huyett

TITLE
Chairman of the Board
COMPENSATION
GEL48K
AGE
62
TENURE
0.6 yrs

Nick Gamkrelidze

TITLE
CEO & Executive Director
COMPENSATION
GEL1M
AGE
38
TENURE
2.9 yrs

Ingeborg Oie

TITLE
Independent Non-Executive Director
COMPENSATION
GEL105K
AGE
33
TENURE
3.6 yrs

Tim Elsigood

TITLE
Independent Non-Executive Director
COMPENSATION
GEL128K
AGE
64
TENURE
3.6 yrs

Mike Anderson

TITLE
Independent Non-Executive Director
COMPENSATION
GEL107K
AGE
66
TENURE
3.6 yrs

David Morrison

TITLE
Senior Independent Non-Executive Director
COMPENSATION
GEL156K
AGE
65
TENURE
3.6 yrs

Irakli Gilauri

TITLE
Non-Executive Director
AGE
42

Jacques Richier

TITLE
Independent Non-Executive Director
COMPENSATION
GEL107K
AGE
63
TENURE
3.6 yrs

Fabian Blank

TITLE
Independent Non-Executive Director
TENURE
0.6 yrs
Who owns this company?
Recent Insider Trading
  • Georgia Healthcare Group insiders have only sold shares in the past 3 months, but not in substantial volumes.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
02. Apr 19 Sell Giorgi Mindiashvili Individual 28. Mar 19 29. Mar 19 -15,186 €2.38 €-35,766
28. Jun 18 Buy Ingeborg Oie Individual 27. Jun 18 27. Jun 18 7,677 €2.88 €22,112
24. May 18 Buy Ingeborg Oie Individual 22. May 18 22. May 18 10,000 €3.42 €34,185
17. May 18 Buy Nikoloz Gamkrelidze Individual 16. May 18 16. May 18 26,944 €3.11 €83,868
X
Management checks
We assess Georgia Healthcare Group's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Georgia Healthcare Group has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

1EB News

Simply Wall St News

1EB Company Info

Description

Georgia Healthcare Group PLC, together with its subsidiaries, provides healthcare services in Georgia. It operates through Healthcare Services, Pharma, and Medical Insurance segments. As of December 31, 2017, the company operated 16 referral and specialty hospitals comprising 2,519 beds that offer secondary and tertiary level healthcare services; 21 community hospitals, including 495 beds providing basic outpatient and inpatient healthcare services; and 255 pharmacies under the GPC and Pharmadepot brand names. It also operates 16 district polyclinics, 24 express outpatient clinics, and dental clinics that offer outpatient diagnostic and treatment services; provides a range of medical insurance products, such as personal accident, term life, and medical and travel insurance policies to corporate and retail clients; and medicines, as well as Para pharmacy products. The company is headquartered in London, the United Kingdom. Georgia Healthcare Group PLC operates as a subsidiary of Georgia Capital PLC.

Details
Name: Georgia Healthcare Group PLC
1EB
Exchange: BST
Founded:
£306,101,032
128,744,547
Website: http://www.ghg.com.ge
Address: Georgia Healthcare Group PLC
84 Brook Street,
London,
Greater London, W1K 5EH,
United Kingdom
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
LSE GHG Common Shares London Stock Exchange GB GBP 09. Nov 2015
BST 1EB Common Shares Boerse-Stuttgart DE EUR 09. Nov 2015
BATS-CHIXE GHGL Common Shares BATS 'Chi-X Europe' GB GBP 09. Nov 2015
Number of employees
Current staff
Staff numbers
16,000
Georgia Healthcare Group employees.
Industry
Drug Retail
Consumer Retailing
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/18 00:27
End of day share price update: 2019/04/17 00:00
Last estimates confirmation: 2019/04/17
Last earnings filing: 2019/04/03
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.